News about Drug Discovery & Development

Nexus Pharmaceuticals Launches Tranexamic Acid

This milestone is another step for Nexus in its mission to provide life-saving medication to those who need it most.

Drug Discovery & Development | 20/03/2025 | By Aishwarya |  414

Akeso Gets NMPA Approval of Penpulimab for Nasopharyngeal Cancer

With this new approval, penpulimab now provides comprehensive treatment coverage across all stages of NPC, offering patients a continuous immunotherapy option from first-line to third-line therapy.

Drug Discovery & Development | 17/03/2025 | By Aishwarya |  483

LGM Pharma Invests USD 6 Million in US Drug Manufacturing Facility

The expansion will increase capacity for liquid, suspension, semi-solid, and suppository drug products, addressing the rising demand for reliable US-based production.

Drug Discovery & Development | 17/03/2025 | By Aishwarya |  359

ENCell Signs MOU with CRC to Enter Japanese Market

Following the latest MoU, the two companies plan to discuss a contractual agreement for the transfer of ENCell’s CDMO technology and expertise.

Drug Discovery & Development | 17/03/2025 | By Aishwarya |  172

Glenmark Unveils Polyethylene Glycol 3350, Powder for Solution, 17 Grams/Capful

Glenmark Pharmaceuticals is a research-led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology.

Drug Discovery & Development | 10/03/2025 | By Aishwarya |  529

Zydus Lifesciences Introduces ANVIMO for Kidney and HSCT Transplant Patients

CMV infection remains one of the most serious complications in transplant patients, often leading to graft failure, decreased survival and prolonged hospital stays.

Drug Discovery & Development | 06/03/2025 | By Aishwarya |  489

Zydus Lifesciences to Launch Protection Against New Strain of Influenza Virus in India

Zydus is set to launch VaxiFlu-4, India’s first quadrivalent influenza vaccine of the season, formulated as per WHO’s 2025 southern hemisphere recommendations.

Drug Discovery & Development | 01/03/2025 | By Manvi |  591

Eisai Signs Deal to Develop Tasurgratinib in Greater China Region with SciClone

Eisai will maintain the rights to tasurgratinib worldwide outside of the licensed regions and continue to manufacture and market it in Japan, where it has been already launched.

Drug Discovery & Development | 01/03/2025 | By Aishwarya |  356

BridGene Biosciences Signs Deal with Takeda to Discover Small Molecule Drugs

Under the terms of the collaboration, BridGene will use its chemoproteomics platform, IMTAC™, to discover novel small molecule drug candidates against challenging targets in immunology and neurology.

Drug Discovery & Development | 26/02/2025 | By Aishwarya |  433

Tiziana Life Sciences Signs Deal for Product Development Services with Renaissance Lakewood

Under this agreement, Renaissance will use its extensive expertise in pharmaceutical-nasal product development and manufacturing to support the production of intranasal foralumab, ensuring compliance with the highest quality and regulatory requirements.

Drug Discovery & Development | 24/02/2025 | By Aishwarya |  190